Cite
Moreira-Soto A, Arguedas M, Brenes H, et al. High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern. Front Med (Lausanne). 2021;8:735853doi: 10.3389/fmed.2021.735853.
Moreira-Soto, A., Arguedas, M., Brenes, H., Buján, W., Corrales-Aguilar, E., Díaz, C., Echeverri, A., Flores-Díaz, M., Gómez, A., Hernández, A., Herrera, M., León, G., Macaya, R., Kühne, A., Molina-Mora, J. A., Mora, J., Sanabria, A., Sánchez, A., Sánchez, L., Segura, �. �., Segura, E., Solano, D., Soto, C., Stynoski, J. L., Vargas, M., Villalta, M., Reusken, C. B. E. M., Drosten, C., Gutiérrez, J. M., Alape-Girón, A., & Drexler, J. F. (2021). High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern. Frontiers in medicine, 8735853. https://doi.org/10.3389/fmed.2021.735853
Moreira-Soto, Andres, et al. "High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern." Frontiers in medicine vol. 8 (2021): 735853. doi: https://doi.org/10.3389/fmed.2021.735853
Moreira-Soto A, Arguedas M, Brenes H, Buján W, Corrales-Aguilar E, Díaz C, Echeverri A, Flores-Díaz M, Gómez A, Hernández A, Herrera M, León G, Macaya R, Kühne A, Molina-Mora JA, Mora J, Sanabria A, Sánchez A, Sánchez L, Segura Á, Segura E, Solano D, Soto C, Stynoski JL, Vargas M, Villalta M, Reusken CBEM, Drosten C, Gutiérrez JM, Alape-Girón A, Drexler JF. High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern. Front Med (Lausanne). 2021 Sep 06;8:735853. doi: 10.3389/fmed.2021.735853. eCollection 2021. PMID: 34552949; PMCID: PMC8451950.
Copy
Download .nbib